Nataliya Volodymyrivna Uboha

机构：Wisconsin Division of Public Health · ORCID：0000-0003-3449-1680

发表论文 275 篇 · 总被引 1794 次 · h-index 19

代表论文

• Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology (2025 · Journal of the National Comprehensive Cancer Network · 被引 205)
• A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma (2024 · Annals of Oncology · 被引 43)
• Olaparib in treatment‐refractory isocitrate dehydrogenase 1 ( IDH1 )– and IDH2 ‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial (2025 · Cancer · 被引 13)
• Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial (2026 · Nature Medicine · 被引 11)
• Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity (2025 · Scientific Reports · 被引 11)
• Adagrasib (Ada) + cetuximab (Cetux) for KRAS G12C -mutated metastatic colorectal cancer (mCRC): Longer follow-up analysis from KRYSTAL-1. (2025 · Journal of Clinical Oncology · 被引 5)